Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization
Stopped Study was terminated early because the site that administered the hyperbaric oxygen treatment closed and an alternative site could not be identified.
Conditions
Interventions
- DRUG: Hyperbaric Oxygen Therapy
Sponsor
University of Arkansas